These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16543079)

  • 41. Reducing antibiotic prescribing in Australian general practice: time for a national strategy.
    Del Mar CB; Scott AM; Glasziou PP; Hoffmann T; van Driel ML; Beller E; Phillips SM; Dartnell J
    Med J Aust; 2017 Nov; 207(9):401-406. PubMed ID: 29092694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.
    Handy LK; Bryan M; Gerber JS; Zaoutis T; Feemster KA
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28270546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults.
    Snow V; Mottur-Pilson C; Gonzales R; ; ; ;
    Ann Intern Med; 2001 Mar; 134(6):487-9. PubMed ID: 11255525
    [No Abstract]   [Full Text] [Related]  

  • 44. [Summary: 15th Consensus conference on antimicrobial therapy for lower respiratory tract infections in immunocompetent adults].
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S131-40. PubMed ID: 17057638
    [No Abstract]   [Full Text] [Related]  

  • 45. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care.
    Steinman MA; Landefeld CS; Gonzales R
    JAMA; 2003 Feb; 289(6):719-25. PubMed ID: 12585950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Rational antibiotic therapy in the dental office: Practical guidelines for decision-making].
    Zadik Y
    Refuat Hapeh Vehashinayim (1993); 2016 Apr; 33(2):50-7, 81. PubMed ID: 27480007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safeguarding future antimicrobial options: strategies to minimize resistance.
    Leclercq R
    Clin Microbiol Infect; 2001; 7 Suppl 3():18-23. PubMed ID: 11523557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
    [No Abstract]   [Full Text] [Related]  

  • 49. Implications for antimicrobial prescribing of strategies based on bacterial eradication.
    Klugman KP
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S27-31. PubMed ID: 12839705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations.
    McCullough AR; Pollack AJ; Plejdrup Hansen M; Glasziou PP; Looke DF; Britt HC; Del Mar CB
    Med J Aust; 2017 Jul; 207(2):65-69. PubMed ID: 28701117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy of cefpodoxime in respiratory tract infection.
    Cohen R
    J Antimicrob Chemother; 2002 Jul; 50 Suppl():23-7. PubMed ID: 12077157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sense and nonsense in antibiotic therapy for respiratory tract infections].
    Domej W; Flögel E; Tilz GP; Demel U
    Internist (Berl); 2005 Jul; 46(7):795-9. PubMed ID: 15815891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Aktas Z; Unal S; van Hasselt J; Seyhun Y; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i51-i60. PubMed ID: 36065733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Any impact of bacterial resistance on antibiotic use in the community?
    Guillemot D; Courvalin P
    Int J Med Microbiol; 2002 Jun; 292(1):1-2. PubMed ID: 12139423
    [No Abstract]   [Full Text] [Related]  

  • 55. Empiric antibiotic selection criteria for respiratory infections in pediatric practice.
    Pichichero ME
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S60-4. PubMed ID: 9076838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescribing practices that promote antibiotic resistance: strategies for change.
    Larrabee T
    J Pediatr Nurs; 2002 Apr; 17(2):126-32. PubMed ID: 12029606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
    Ehrhardt AF; Russo R
    Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changing the Antibiotic Prescribing of general practice registrars: the ChAP study protocol for a prospective controlled study of a multimodal educational intervention.
    van Driel ML; Morgan S; Tapley A; McArthur L; McElduff P; Yardley L; Dallas A; Deckx L; Mulquiney K; Davis JS; Davey A; Henderson K; Little P; Magin PJ
    BMC Fam Pract; 2016 Jun; 17():67. PubMed ID: 27267983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
    File TM
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What new antibiotics to offer in the outpatient setting.
    Fraser KL; Grossman RF
    Semin Respir Infect; 1998 Mar; 13(1):24-35. PubMed ID: 9543473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.